Clinical Characteristics of men with serum PSA>4.0ng/ml before 50 years: a single center based study

Zhongwei Yu,Fukang Sun
DOI: https://doi.org/10.3969/j.issn.1008-0848.2017.03.002
2017-01-01
Abstract:Objective To figure out the reason why serum prostate-specific antigen (PSA) is elevated in men before 50 years and how to manage it.Methods We retrospectively reviewed clinical data of 321 patients with a PSA serum concentration of more than 4ng/ml from 2012 to 2015 in our center. The level of PSA, fPSA/tPSA and prostate biopsy outcome were comparatively analyzed between patients before and after 50 years old.Results Of 321 patients, 53 patients are no elder than 50 years old, with mean age 40 years (21-50 years). The level of serum PSA and fPSA/tPSA value in patients≤50 years at diagnosis are (7.645±2.734)ng/mL and (0.090±0.048) respectively. serum PSA level and fPSA/tPSA value in patients≤50 years old are significantly lower than in patient >50 years old. Combination of tamsulosin and ciprofloxacin therapy failed to decrease serum PSA in patients younger than 50 years old. 19 patients were applied to transrectal ultrasound guided prostate biopsy and turned out to be with negative outcome.Conclusion Our study suggest that elevated serum PSA level in patients≤50 years was mainly caused by chronic prostatitis and benign prostate hyperplasia. PSA are mainly moderately elevated and mostly range from 4.0~10ng/mL in men younger than 50 years. Active surveillance is a proper choice for these patients.
What problem does this paper attempt to address?